Evotec AG Shares Outstanding 2012-2025 | EVO

Evotec AG shares outstanding from 2012 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Evotec AG Annual Shares Outstanding
(Millions of Shares)
2024 355
2023 354
2022 353
2021 333
2020 308
2019 299
2018 295
2017 290
2016 265
2015 263
2014 263
2013 242
2012 235
2011 225
Evotec AG Quarterly Shares Outstanding
(Millions of Shares)
2025-09-30 355
2025-06-30 355
2025-03-31 355
2024-12-31 355
2024-09-30 355
2024-06-30 355
2024-03-31 355
2023-09-30 354
2023-06-30 354
2022-12-31 353
2022-09-30 353
2022-06-30 353
2022-03-31 353
2021-12-31 333
2021-09-30 329
2021-06-30 329
2021-03-31 328
2020-12-31 308
2020-09-30 302
2020-06-30 302
2020-03-31 302
2019-12-31 299
2019-09-30 300
2019-06-30 299
2019-03-31 298
2018-12-31 295
2018-09-30 295
2018-06-30 295
2018-03-31 295
2017-12-31 290
2017-09-30 291
2017-06-30 293
2017-03-31 279
2016-12-31 265
2016-09-30 265
2016-06-30 265
2016-03-31 265
2015-12-31 263
2015-09-30 263
2015-06-30 263
2015-03-31 263
2014-12-31 203
2014-09-30 263
2014-06-30 263
2014-03-31 262
2013-12-31 242
2013-09-30 238
2013-06-30 236
2013-03-31 236
2012-12-31 234
2012-09-30 235
2012-06-30 245
2012-03-31 199
2011-12-31 242
2011-09-30 234
2011-06-30 243
2011-03-31 229
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.279B $0.862B
EVOTEC is a leader in the discovery and development of novel small molecule drugs. They have established a powerful platform that is applicable to targets across all therapeutic areas and has specific expertise in the area of Central Nervous System related diseases where it is building a pipeline of drug candidates for partnering. Through research collaborations and proprietary projects They are providing the highest quality research results to its partners in the pharmaceutical and biotechnology industries
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $96.263B 33.62
Takeda Pharmaceutical (TAK) Japan $57.594B 11.31
Zoetis (ZTS) United States $56.466B 20.21
BeOne Medicines - (ONC) Switzerland $38.758B 205.48
Daiichi Sankyo, - (DSNKY) Japan $36.201B 18.03
Sandoz Group AG (SDZNY) Switzerland $35.913B 0.00
United Therapeutics (UTHR) United States $20.374B 17.93
Merck (MKKGY) Germany $19.309B 11.90
Shionogi (SGIOY) Japan $19.158B 14.82
Neurocrine Biosciences (NBIX) United States $13.724B 32.93
Ionis Pharmaceuticals (IONS) United States $13.653B 0.00
IPSEN (IPSEY) France $13.565B 0.00
Summit Therapeutics (SMMT) United States $11.760B 0.00
Orion OYJ (ORINY) Finland $11.502B 32.86
Madrigal Pharmaceuticals (MDGL) United States $10.875B 0.00
Eisai (ESAIY) $9.041B 0.00
Ono Pharmaceutical (OPHLF) Japan $7.771B 18.59
Crinetics Pharmaceuticals (CRNX) United States $4.864B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.640B 22.03
Stevanato Group S.p.A (STVN) Italy $4.612B 25.81
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.591B 0.00
Corcept Therapeutics (CORT) United States $4.310B 46.56
Indivior Pharmaceuticals (INDV) United States $4.183B 17.07
NewAmsterdam Pharma (NAMS) Netherlands $3.956B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $3.166B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.983B 9.52
Hypermarcas (HYPMY) Brazil $2.825B 19.39
Dyne Therapeutics (DYN) United States $2.448B 0.00
Soleno Therapeutics (SLNO) United States $2.175B 0.00
Guardian Pharmacy Services (GRDN) United States $2.140B 41.22
Avadel Pharmaceuticals (AVDL) Ireland $2.112B 0.00
Ocular Therapeutix (OCUL) United States $1.966B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.920B 22.75
Ardelyx (ARDX) United States $1.774B 0.00
Harrow (HROW) United States $1.767B 108.43
Definium Therapeutics (DFTX) United States $1.711B 0.00
Enliven Therapeutics (ELVN) United States $1.658B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.635B 0.00
Oruka Therapeutics (ORKA) United States $1.592B 0.00
Relay Therapeutics (RLAY) United States $1.558B 0.00
Collegium Pharmaceutical (COLL) United States $1.478B 7.32
BioCryst Pharmaceuticals (BCRX) United States $1.380B 81.88
Xeris Biopharma Holdings (XERS) United States $1.198B 0.00
Nektar Therapeutics (NKTR) United States $1.139B 0.00
Savara (SVRA) United States $1.072B 0.00
Cronos Group (CRON) Canada $1.011B 0.00
Theravance Biopharma (TBPH) United States $0.983B 41.28
ARS Pharmaceuticals (SPRY) United States $0.981B 0.00
Aktis Oncology (AKTS) United States $0.902B 0.00
Xencor (XNCR) United States $0.883B 0.00
Esperion Therapeutics (ESPR) United States $0.810B 0.00
KalVista Pharmaceuticals (KALV) United States $0.759B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.747B 17.65
Bioventus (BVS) United States $0.668B 13.68
Rigel Pharmaceuticals (RIGL) United States $0.628B 5.61
ProKidney (PROK) United States $0.605B 0.00
Altimmune (ALT) United States $0.525B 0.00
4D Molecular Therapeutics (FDMT) United States $0.520B 0.00
Lexeo Therapeutics (LXEO) United States $0.514B 0.00
Lyell Immunopharma (LYEL) United States $0.504B 0.00
Organogenesis (ORGO) United States $0.487B 0.00
Zevra Therapeutics (ZVRA) United States $0.485B 0.00
Siga Technologies (SIGA) United States $0.479B 6.56
Elite Pharmaceuticals (ELTP) United States $0.474B 0.00
Aquestive Therapeutics (AQST) United States $0.471B 0.00
Nature's Sunshine Products (NATR) United States $0.444B 26.43
Akebia Therapeutics (AKBA) United States $0.401B 0.00
Aclaris Therapeutics (ACRS) United States $0.395B 0.00
USANA Health Sciences (USNA) United States $0.392B 10.93
Protara Therapeutics (TARA) United States $0.333B 0.00
Aldeyra Therapeutics (ALDX) United States $0.330B 0.00
Cybin (HELP) Canada $0.320B 0.00
Relmada Therapeutics (RLMD) United States $0.295B 0.00
Larimar Therapeutics (LRMR) United States $0.276B 0.00
Minerva Neurosciences (NERV) United States $0.273B 0.00
Enlivex Therapeutics (ENLV) Israel $0.273B 0.00
Avalo Therapeutics (AVTX) United States $0.270B 0.00
Journey Medical (DERM) United States $0.269B 0.00
OmniAb (OABI) United States $0.249B 0.00
Heron Therapeutics (HRTX) United States $0.233B 0.00
Achieve Life Sciences (ACHV) Canada $0.232B 0.00
Profound Medical (PROF) Canada $0.231B 0.00
MediWound (MDWD) Israel $0.226B 0.00
Context Therapeutics (CNTX) United States $0.217B 0.00
Silence Therapeutics (SLN) United Kingdom $0.212B 0.00
Surrozen (SRZN) United States $0.196B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.194B 0.00
Innate Pharma SA (IPHYF) France $0.181B 0.00
Galectin Therapeutics (GALT) United States $0.178B 0.00
AleAnna (ANNA) United States $0.173B 0.00
Century Therapeutics (IPSC) United States $0.169B 0.00
VAXART, INC (VXRT) United States $0.142B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.139B 0.00
Unicycive Therapeutics (UNCY) United States $0.137B 0.00
Prelude Therapeutics (PRLD) United States $0.132B 0.00
Avita Medical (RCEL) United States $0.122B 0.00
Karyopharm Therapeutics (KPTI) United States $0.121B 0.00
Cardiol Therapeutics (CRDL) Canada $0.121B 0.00
Inhibikase Therapeutics (IKT) United States $0.120B 0.00
Korro Bio (KRRO) United States $0.114B 0.00
Cassava Sciences (SAVA) United States $0.105B 0.00
Vivani Medical (VANI) United States $0.098B 0.00
Incannex Healthcare (IXHL) Australia $0.098B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.096B 0.00
Pyxis Oncology (PYXS) United States $0.087B 0.00
Champions Oncology (CSBR) United States $0.085B 36.00
Assertio Holdings (ASRT) United States $0.075B 0.00
PolyPid (PYPD) Israel $0.074B 0.00
HST Global (HSTC) United States $0.069B 0.00
Gain Therapeutics (GANX) United States $0.068B 0.00
PMV Pharmaceuticals (PMVP) United States $0.062B 0.00
Rafael Holdings (RFL) United States $0.062B 0.00
Fractyl Health (GUTS) United States $0.061B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.058B 48.25
Dominari Holdings (DOMH) United States $0.056B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.056B 0.00
NRx Pharmaceuticals (NRXP) United States $0.056B 0.00
Nutriband (NTRB) United States $0.053B 0.00
BioNxt Solutions (BNXTF) Canada $0.051B 0.00
Acrivon Therapeutics (ACRV) United States $0.049B 0.00
Lipocine (LPCN) United States $0.049B 0.00
ElectroCore (ECOR) United States $0.043B 0.00
Telomir Pharmaceuticals (TELO) United States $0.040B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Talphera (TLPH) United States $0.039B 0.00
Lite Strategy (LITS) United States $0.038B 0.00
Plus Therapeutics (PSTV) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Liminatus Pharma (LIMN) United States $0.034B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.030B 0.00
TherapeuticsMD (TXMD) United States $0.028B 0.00
Wellgistics Health (WGRX) United States $0.027B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.026B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Scienture Holdings (SCNX) United States $0.019B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Klotho Neurosciences (KLTO) United States $0.017B 0.00
Citius Pharmaceuticals (CTXR) United States $0.017B 0.00
Iterum Therapeutics (ITRM) Ireland $0.016B 0.00
Vivos Therapeutics (VVOS) United States $0.016B 0.00
Cosmos Health (COSM) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.015B 0.02
Vyome Holdings (HIND) United States $0.015B 0.00
Mannatech (MTEX) United States $0.014B 0.00
BioLineRx (BLRX) Israel $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Tempest Therapeutics (TPST) United States $0.012B 0.00
Inotiv (NOTV) United States $0.011B 0.00
CASI Pharmaceuticals (CASI) China $0.010B 0.00
TransCode Therapeutics (RNAZ) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
BioVie (BIVI) United States $0.009B 0.00
Ainos (AIMD) United States $0.009B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Lyra Therapeutics (LYRA) United States $0.003B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Ernexa Therapeutics (ERNA) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
CDT Equity (CDT) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00